Latest

2 stories

Hide weekly roundups

Thursday, September 10

Quarterly updateChampions Oncology, Inc.

Champions Oncology posts 8.8% revenue growth and wider margins in fiscal Q1 2027

The oncology research services firm reported $15.2 million in quarterly revenue, improved oncology services margin, and higher adjusted EBITDA, while cash fell to $4.4 million.

SEC filing

Monday, July 27

Quarterly updateChampions Oncology, Inc.

Champions Oncology posts record $59.4 million fiscal 2026 revenue

The oncology research company reported four straight quarters of positive adjusted EBITDA and continued investment in radiopharmaceuticals and its data platform.

SEC filing